Diakonos Oncology, a clinical-stage biotechnology company leveraging proprietary dendritic cell technology to address critical and unmet therapeutic needs in late-stage and aggressive cancers,...

Owl Therapeutics ("Owl"), a biopharmaceutical company developing drugs to supercharge microglia, the immune cells of the brain, announces that Chief Executive Officer William E. Haskins, Ph.D....

Highlighting advancements in glycan-directed cancer immunotherapies and biosimilars NEW TAIPEI CITY, Taiwan, Jan. 8, 2025 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), a...

Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, will present its latest breakthrough immunocytokine, FP008, on Jan 14, 2025, at the Biotech Showcase...

Presentation by CEO Mark Engel Highlighting both Platform and Product Pipeline Advances DOVER, Del., Jan. 5, 2024 /PRNewswire/ -- Precisio Biotix today announced that it is presenting at both the...